Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prophase Labs Inc 711 STEWART AVENUE SUITE 200 GARDEN CITY NY 11530 USA

www.prophaselabs.com P: 215-345-0919 F: 215-345-5920

Description:

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE', a zinc gluconate glycine product. COLD-EEZE' family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 111,067
Enterprise Value, $K 111,837
Shares Outstanding, K 18,045
Annual Sales, $ 44,380 K
Annual Net Income, $ -16,780 K
Last Quarter Sales, $ 3,500 K
Last Quarter Net Income, $ -8,750 K
EBIT, $ -21,620 K
EBITDA, $ -14,790 K
60-Month Beta -0.29
% of Insider Shareholders 26.10%
% of Institutional Shareholders 9.45%
Float, K 13,335
% Float 73.90%
Short Volume Ratio 0.30

Growth:

1-Year Return -24.57%
3-Year Return 17.69%
5-Year Return 105.17%
5-Year Revenue Growth 238.00%
5-Year Earnings Growth -600.00%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings -0.51 on 03/28/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -0.98
EPS Growth vs. Prev Qtr -70.00%
EPS Growth vs. Prev Year -537.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PRPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.83%
Return-on-Assets % -18.14%
Profit Margin % -37.81%
Debt/Equity 0.06
Price/Sales 2.65
Price/Cash Flow N/A
Price/Book 2.38
Book Value/Share 2.74
Interest Coverage -16.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar